Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL23326865

COC(=O)c1ccc[n+](Cc2cn(-c3ccccc3)nn2)c1.O=C([O-])C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 2/20 0.43
NPC1 O15118 1/20 0.43
MIF P14174 1/20 0.41
PSMD10 O75832 1/20 0.41
APP P05067 3/20 0.40
ALDH1A1 P00352 1/20 0.40
RECQL P46063 1/20 0.40
GLA P06280 1/20 0.39
AURKA O14965 1/20 0.39
AURKB Q96GD4 1/20 0.39
NOTUM Q6P988 1/20 0.39
ESRRA P11474 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA9 Q16790 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL23326692 0.89 L3MBTL1 (0.47) L3MBTL1POLBNPC1MIFPSMD10
Trifluoroacetic Acid SCHEMBL30801355 0.86 MIF (0.43) L3MBTL1POLBNPC1MIFAPP
SCHEMBL30801359 0.81 L3MBTL1 (0.55) L3MBTL1POLBNPC1MIFPSMD10
Trifluoroacetic Acid SCHEMBL30801352 0.77 MIF (0.45) L3MBTL1POLBNPC1MIFAPP
SCHEMBL23326579 0.76 GLA (0.46) L3MBTL1POLBNPC1MIFAPP
SCHEMBL23326705 0.72 MAOA (0.43) L3MBTL1POLBNPC1MIFAPP
Trifluoromethanesulfonic Acid SCHEMBL5672061 0.70 NPSR1 (0.52) L3MBTL1ALDH1A1RECQLGLACA1
Formic Acid SCHEMBL30801353 0.69 NOTUM (0.38) L3MBTL1POLBNPC1MIFAPP
Formic Acid SCHEMBL30801354 0.69 NOTUM (0.38) L3MBTL1POLBNPC1MIFAPP
Bromide SCHEMBL9155378 0.68 NPSR1 (0.62) L3MBTL1ALDH1A1RECQLGLACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11885818-B2 Reagent for mass spectrometry ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2024-01-30 US disclosed
US-20210140983-A1 REAGENT FOR MASS SPECTROMETRY ROCHE DIAGNOSTICS OPERATIONS, INC. 2021-05-13 US disclosed
CN-112492881-A Reagent for mass spectrometry 豪夫迈·罗氏有限公司 2021-03-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210140983-A1 REAGENT FOR MASS SPECTROMETRY SRMS, PTMS, MMAB L3MBTL1 2526/4885POLB 3320/4885NPC1 3023/4885
US-11885818-B2 Reagent for mass spectrometry SRMS, PTMS, MMAB L3MBTL1 2526/4885POLB 3320/4885NPC1 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.